SCHEMBL7080966

SCHEMBL7080966

O=C(O)CC(CS(=O)(=O)c1ccc(CCc2cccc(NC(=O)c3ccccn3)c2)cc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.47
GRM4 Q14833 8/20 0.46
HDAC6 Q9UBN7 1/20 0.46
KCNK3 O14649 1/20 0.45
KCNK9 Q9NPC2 1/20 0.45
GAA P10253 2/20 0.44
KDM4E B2RXH2 1/20 0.44
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
ALDH1A1 P00352 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ATM Q13315 1/20 0.41
PDE5A O76074 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7130131 0.86 ITGB3 (0.46) KDM4EALDH1A1SMN1; SMN2HTT
SCHEMBL7135413 0.84 GRM4 (0.53) GRM4GAAKDM4ELMNASMN1; SMN2
SCHEMBL7080988 0.81 ITGB3 (0.44) LMNAALDH1A1SMN1; SMN2HTTMEN1
SCHEMBL7162980 0.80 ITGB3 (0.36) LMNASMN1; SMN2HTT
SCHEMBL10279296 0.79 CA12 (0.40)
SCHEMBL7079926 0.77 MAOA (0.48) ALDH1A1ATM
SCHEMBL7079307 0.76 BDKRB1 (0.34) ALDH1A1ATM
SCHEMBL7076145 0.76 BDKRB1 (0.34) ALDH1A1ATM
SCHEMBL7075687 0.76 BDKRB1 (0.34) ALDH1A1ATM
SCHEMBL7131622 0.74 MMP2 (0.33) GAALMNAALDH1A1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003059872-A1 AVB3 AND AVB5 INTEGRIN ANTAGONISTS AND METHODS OF TREATING DISEASES OR CONDITIONS ASSOCIATED WITH AVB3 AND AVB5 INTEGRINS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-24 WO disclosed